These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9831395)

  • 1. New ligands for HLA DRB1*0301 by random selection of favourable amino acids ranked by competition studies with undecapeptide amide sublibraries.
    Jung C; Kalbus M; Fleckenstein B; Melms A; Jung G; Wiesmüller KH
    J Immunol Methods; 1998 Oct; 219(1-2):139-49. PubMed ID: 9831395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library.
    Fleckenstein B; Kalbacher H; Muller CP; Stoll D; Halder T; Jung G; Wiesmüller KH
    Eur J Biochem; 1996 Aug; 240(1):71-7. PubMed ID: 8797837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
    Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.
    Matsushita S; Takahashi K; Motoki M; Komoriya K; Ikagawa S; Nishimura Y
    J Exp Med; 1994 Sep; 180(3):873-83. PubMed ID: 8064238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.
    Hill CM; Liu A; Marshall KW; Mayer J; Jorgensen B; Yuan B; Cubbon RM; Nichols EA; Wicker LS; Rothbard JB
    J Immunol; 1994 Mar; 152(6):2890-8. PubMed ID: 8144889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific and general HLA-DR binding motifs: comparison of algorithms.
    Borrás-Cuesta F; Golvano J; García-Granero M; Sarobe P; Riezu-Boj J; Huarte E; Lasarte J
    Hum Immunol; 2000 Mar; 61(3):266-78. PubMed ID: 10689116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis.
    Odunsi K; Ganesan T
    Int J Mol Med; 2001 Oct; 8(4):405-12. PubMed ID: 11562779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.
    Hammer J; Belunis C; Bolin D; Papadopoulos J; Walsky R; Higelin J; Danho W; Sinigaglia F; Nagy ZA
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4456-60. PubMed ID: 8183931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.
    Marshall KW; Liu AF; Canales J; Perahia B; Jorgensen B; Gantzos RD; Aguilar B; Devaux B; Rothbard JB
    J Immunol; 1994 May; 152(10):4946-57. PubMed ID: 8176213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-binding characteristics of the novel allele DRB1*0112 are probably identical to DRB1*0101.
    Horn PA; DeLuca DS; Mueller K; Blasczyk R
    Tissue Antigens; 2005 May; 65(5):505-6. PubMed ID: 15853910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Several common HLA-DR types share largely overlapping peptide binding repertoires.
    Southwood S; Sidney J; Kondo A; del Guercio MF; Appella E; Hoffman S; Kubo RT; Chesnut RW; Grey HM; Sette A
    J Immunol; 1998 Apr; 160(7):3363-73. PubMed ID: 9531296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif.
    Wymann D; Blüggel M; Kalbacher H; Blesken T; Akdis CA; Meyer HE; Blaser K
    Immunology; 1999 Jan; 96(1):1-9. PubMed ID: 10233671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of anchor residues in a naturally processed HLA-DR53 ligand.
    Kobayashi H; Kokubo T; Abe Y; Sato K; Kimura S; Miyokawa N; Katagiri M
    Immunogenetics; 1996; 44(5):366-71. PubMed ID: 8781122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.